Andrew Saik Insider Trading $MNLO VYNE Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Saik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Saik. Andrew Saik is CFO in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Financial Officer in Edge Therapeutics, Inc. ($EDGE) and Chief Financial Officer in Menlo Therapeutics Inc. ($MNLO).
Andrew Saik in VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Saik: Chief Financial Officer
Holdings: 113,451 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew Saik in VYNE Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AUXL, EDGE, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Payment of Exercise | F | 6.84 | 762 | 5,212 | 113,451 | 114.2 K to 113.5 K (-0.67 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |
| May 08 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 1.95 | 250,000 | 487,500 | 250,000 | |
| May 08 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 250,000 | 0 | 300,000 | 50 K to 300 K (+500.00 %) |
| Mar 24 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 3.13 | 100,000 | 313,000 | 100,000 | |
| Mar 24 2020 | MNLO | Menlo Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1